when to stop glp-1 before surgery Guidelines: Procedures Stopping GLP-1 Prior to Surgery:

These results encouraged the possibility that a clinically useful drug can be designed possessing oral efficacy, BBB penetrability, increased metabolic stability, coupled with facilitated cognitive functioning

Patients on tirzepatide lost an average of 20.2% of their body weight over 72 weeks, compared to 13.7% with semaglutide.[1] That gap is not small, and for patients in Shreveport asking which medication is the better choice, this study provides the clearest evidence yet

doi: 10.3389/fvets.2021.769837 26 GalvisRDMadridLVRamrez-VsquezN

Months 4-6 Over the next three months of Marissas program, we ordered some additional tests to further refine our diagnostic thinking and treatment approach